| Title : Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914\/SEN34625 - Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| Author(s) : Marquis KL , Comery TA , Jow F , Navarra RL , Grauer SM , Pulicicchio C , Kelley C , Brennan JA , Roncarati R , Scali C , Haydar S , Ghiron C , Terstappen GC , Dunlop J |
| Ref : Psychopharmacology (Berl) , 218 :635 , 2011 |
| Abstract : Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| ESTHER : Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| PubMedSearch : Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| PubMedID: 21643676 |
Marquis KL, Comery TA, Jow F, Navarra RL, Grauer SM, Pulicicchio C, Kelley C, Brennan JA, Roncarati R, Scali C, Haydar S, Ghiron C, Terstappen GC, Dunlop J (2011)
Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914\/SEN34625
Psychopharmacology (Berl)
218 :635
Marquis KL, Comery TA, Jow F, Navarra RL, Grauer SM, Pulicicchio C, Kelley C, Brennan JA, Roncarati R, Scali C, Haydar S, Ghiron C, Terstappen GC, Dunlop J (2011)
Psychopharmacology (Berl)
218 :635